MS MPJE common mistakes
MS MPJE · Understand the traps and how to avoid them.
Answers Mississippi authority questions by citing only the Pharmacy Practice Act and omits Board of Pharmacy regulations.
Candidates study the statute as the complete body of law and treat Board rules as non-testable guidance.
What to do instead
Create a two-column outline for each topic: statute requirement versus Board rule requirement. Flag where the Board adds permitting, documentation, reporting, or disciplinary provisions.
Uses the federal CSA schedule as the final answer for a Mississippi controlled-substance question without checking Mississippi's schedule or state-specific restrictions.
Federal scheduling is more familiar and easier to memorize than state schedule variations.
What to do instead
Build a federal-versus-Mississippi comparison table for each schedule and flag state additions, prescriber limits, and prescription monitoring reporting duties.
Applies one retention period to prescriptions, controlled-substance records, and general pharmacy business records.
The federal two-year CSA recordkeeping rule is salient and gets overgeneralized to every record type.
What to do instead
Make a record-type matrix listing the governing source, whether federal or Mississippi, and the retention and availability requirement for each record class; verify the current Board rule before the exam.
Assumes a pharmacist licensed in another state can transfer licensure to Mississippi by endorsement without meeting Mississippi-specific application, examination, or internship requirements.
Reciprocity language is common in other states, and candidates conflate score transfer, endorsement, and reciprocity.
What to do instead
Outline each pathway separately: initial licensure, score transfer, licensure by reciprocity or endorsement, and reinstatement. List the Mississippi documentation and examination requirements for each.
Counsels only when dispensing a new prescription and does not address refills, patient refusal, or documentation of the counseling offer.
Retail workflow habits and general counseling standards lead candidates to treat counseling as a new-prescription event only.
What to do instead
Use a counseling checklist that covers the offer at every dispensing, refusal documentation, language or access accommodations, and the pharmacist's responsibility for patient understanding.
Treats a compounded preparation as FDA-approved because the active ingredient is FDA-approved.
Candidates confuse approval of an ingredient with approval of a finished drug product.
What to do instead
Separate FDA approval of a manufactured product from state-regulated compounding. Never describe a compounded drug as FDA-approved, and note labeling and marketing limits for compounded preparations.
Omits the biennial controlled-substance inventory, DEA Form 222 or power of attorney, and receipt and dispensing records when asked what records a pharmacy must maintain.
Candidates memorize schedule lists but not the operational record set that supports controlled-substance accountability.
What to do instead
Use a CSA operational checklist: registration, biennial inventory, order forms and power of attorney, receipts, dispensing records, returns and destruction, and theft or loss reporting.
Assumes any DEA-registered prescriber may authorize any controlled substance in Mississippi without verifying state licensure, Mississippi controlled-substance authority, or state schedule restrictions.
Federal DEA registration is visible and seems sufficient, so state-level prescriber authority is overlooked.
What to do instead
For each controlled-substance prescription, verify the prescriber's state license, DEA registration, Mississippi controlled-substance authority, and any schedule-specific limits. Create a verification sequence and apply it to every practice question.
Assumes all compounding is exempt from FDA requirements and that office-use compounding can be performed without a patient-specific prescription or Board authorization.
The compounding exemption is taught broadly, while state limits on office-use and sterile compounding are less familiar.
What to do instead
Distinguish patient-specific versus office-use compounding and sterile versus nonsterile compounding. List Mississippi Board requirements for prescriptions, beyond-use dates, and facility standards.
Responds to a theft or significant loss of controlled substances by notifying only local police and does not notify DEA and the Mississippi Board within required timeframes.
Candidates treat the event as a security incident rather than a regulatory reporting event.
What to do instead
Use a controlled-substance loss checklist that includes internal escalation, DEA reporting, Mississippi Board reporting, inventory reconciliation, and documentation of the notifications.